TOLFEDINE TABLET 60 MG

Land: Malasía

Tungumál: enska

Heimild: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Virkt innihaldsefni:

TOLFENAMIC ACID

Fáanlegur frá:

Gladron Chemicals Sdn Bhd

INN (Alþjóðlegt nafn):

TOLFENAMIC ACID

Einingar í pakka:

96.00 mcg/mL; 100.00 mcg/mL; 20.00 mcg/mL; 16.00 mcg/mL

Framleitt af:

Vetoquinol

Vara einkenni

TO BE SUPPLIED ONLY ON VETERINARY PRESCRIPTION
KEEP OUT OF REACH OF CHILDREN / JAUHI DARIPADA KANAK-KANAK
STORE IN A DRY PLACE - DO NOT STORE ABOVE 25° C
KEEP BLISTER STRIPS IN OUTER CARTON
MANUFACTURED BY:
VETOQUINOL
Magny Vernois
70200 Lure (France)
To be supplied only on veterinary prescription
REGISTRATION HOLDER:
Gladron Chemicals Sdn. Bhd.
No.7, Jalan TP7,
UEP Industrial Park,
40400 Shah Alam,
Selangor Darul Ehsan.
Dispose of used packaging in the household refuse.
Unused product should be returned to the veterinary surgeon.
FOR ANIMAL TREATMENT ONLY
_VETERINARY PHARMACEUTICALS_
70200 LURE (France)
TOLFEDINE
®
TABLETS 60 MG
NON STEROIDAL ANTI-INFLAMMATORY - ANALGESIC - ANTIPYRETIC
Each tablet contains: 60mg tolfenamic acid active ingredient
White, convex and divisible in two tablets (scored tablets) with
average
mass of 0.394g
Tablets are packed in PVC/Aluminium blisters.
Box of 16 tablets (2 blisters of 8 tablets)
Box of 96 tablets (12 blisters of 8 tablets)
Box of 20 tablets (2 blisters of 10 tablets)
Box of 100 tablets (10 blisters of 10 tablets)
INDICATIONS
Dogs:
Treatment for alleviation of acute episodes of inflammation and
pain in chronic locomotor disease.
_DIMENSIONS : 160x120 mm pliée_
_RÉFÉRENCE ARTICLE : 412849 0611 E_
_NOM DU PRODUIT :_
_Notice Tolfédine 60mg MALAISIE_
_1 COULEUR_
_BLEU NUIT 281 U_
_CRÉÉ PAR : P. Mougenot_
_LE : _
_VISA :_
_REV E_
_VÉTOQUINOL _
PHARMACODYNAMIC PROPERTIES
Tolfenamic
acid
(N‑(2‑methyl‑3‑chlorophenyl)
anthranilic
acid)
is
a
non-steroidal anti-inflammatory drug belonging to the fenamate group.
Tolfenamic acid possesses anti-inflammatory, analgesic and antipyretic
properties.
The anti-inflammatory activity of tolfenamic acid is especially due to
an
inhibition of cyclooxygenase leading to a reduction of prostaglandin
synthesis and thromboxanes, major inflammatory mediators.
PHARMACOKINETIC PROPERTIES:
ABSORPTION
tolfenamic acid is rapidly absorbed. After a single oral
administration of
4mg/kg tolfenamic acid, the mean maximal plasma concentration (Cm